HiLIFE supports commercialization of research

In December 2017, Helsinki Institute of Life Science HiLIFE divided the total of € 347,900 Proof of Concept Grants between seven projects to accelerate the commercialization of research findings and development of novel technologies. The deadlines for 2018 applications are 5 March, 1 June, and 15 October.

 can be applied by University of Helsinki life science researchers with a doctorate who consider or are already involved in an invention disclosure to , or listed as inventors on a pending patent application owned by University of Helsinki.

More information on how to apply can be found at: . In 2018, the deadlines for applications are 5 March, 1 June, and 15 October.

"We are happy to see an increasing interest in these grants," says Pia Runeberg-Roos from HiLIFE.

The first HiPoC Grants were awarded in October 2017 (see ), and in December the Grant was awarded to the following researchers and projects:

, 48516 euro 

Development of a novel virus Modified in vitro Translation system (vMiT)

, 50000 euro

THE DENVAX PROJECT - manipulating dendritic cells to improve cancer immunotherapy

, 50000 euro

Proof-of-concept studies related to a mobile digital microscope scanner (MoMic) towards a product for point-of-care diagnostics

, 49380 euro

Data visualization library for web publishing

, 50000 euro

Prolyl oligopeptidase ligands - a possibility for a common drug therapy for several neurodegenerative diseases?

, 50000 euro

Novel cell barcoding method for genomic and transcriptomic profiling of single cells in suspensions and tissues in situ

, 50000 euro 

Next generation CDNF in the treatment of Parkinson’s disease

For more information, contact Pia Runeberg-Roos,